Breast cancer is a complex disease encompassing multiple tumor entities, each
characterized by distinct morphology, behavior and clinical implications. Besides estrogen …

Midkine is a heparin-binding growth factor, originally reported as the product of a retinoic
acid-responsive gene during embryogenesis, but currently viewed as a multifaceted factor …

Breast cancer (BC) is a heterogeneous disease, encompassing a diverse spectrum of
tumours with varying morphological, biological, and clinical phenotypes. Although tumours …

Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and
molecular properties. Traditional classification use morphology to divide tumors into …

The International Agency for Research on Cancer (IARC) has recently reported a 66%
increase in the global number of cancer deaths since 1960. In the US alone, about one in …

Increased understanding of the molecular heterogeneity that is intrinsic to the various
subtypes of breast cancer will likely shape the future of breast cancer diagnosis, prognosis …

Although programmed death-ligand 1 (PD-L1) inhibitors have achieved some therapeutic
success in breast cancer, their efficacy is limited by low therapeutic response rates, which is …

Breast cancer is a complex, multifaceted disease encompassing a great variety of entities
that show considerable variation in clinical, morphological and molecular attributes …

Purpose: We aimed to develop an ovarian cancer–specific predictive framework for clinical
stage, histotype, residual tumor burden, and prognosis using machine learning methods …

Endothelium is a community of endothelial cells (ECs), which line the blood and lymphatic
vessels, thus forming an interface between the tissues and the blood or lympha. This …